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The aim of the present study was transmembrane pressure
(TMP) modulation in high-volume mixed hemodiafiltration
(HDF) to optimize efficiency and minimize protein loss. The
optimal flow/pressure conditions in on-line mixed HDF
assisted with a feedback control of TMP were defined in this
prospective randomized study in order to obtain maximal
efficiency in solute removal while minimizing potential side
effects. Two different TMP profiles in mixed HDF were
compared in 12 unselected patients who underwent two
study periods of 2 weeks each in cross-over randomized
sequence: (A) constant TMP at around 300 mmHg and (B)
profiled TMP, in which TMP was slowly increased from a low
initial value to the maximal value. In both procedures, the
mean volume exchange was 10.671.4 l/h. Mean filtration
fraction was 53%. Instantaneous b2-microglobulin (b2-m)
clearance was higher at the start of the session with profiled
TMP (207735 vs 194728 ml/min, Po0.005), whereas no
differences were found at the end (135719 vs 132719 ml/
min). Profiled TMP resulted in a higher mean b2-m clearance
of the session (97.0715.4 vs 87.8718.3 ml/min, Po0.01), in
lower albumin loss in the first 30 min (0.6270.14 vs
0.9870.18 g, Po0.0001), and, in the whole session
(3.9871.19 vs 5.2470.77 g, Po0.001), in higher dialyzer
ultrafiltration coefficients and lower resistance indexes. This
study showed that the TMP feedback modulation in mixed
HDF was highly effective in maintaining very high ultra-
filtration rates and filtration fractions, and minimized
potential side effects as a result of the improved preservation
of membrane permeability and more favorable dialyzer
pressure regimen.
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Convincing evidence exists that hemodiafiltration (HDF),
compared to standard hemodialysis techniques, including
high-flux hemodialysis, helps to remove a larger amount of
middle molecular compounds,1–9 which have a pathogenic
role or are markers of the most frequent long-term
complications and causes of death in hemodialysis patients,
such as dialysis-related amyloidosis, cardiovascular disease,
inflammation, and malnutrition. Anemia and iperphospha-
temia also seem to be better controlled with HDF.10–13
Indeed, solute removal obtained by coupling diffusion and
convection in HDF is definitely higher than that attainable by
‘internal filtration’ in high-flux hemodialysis, provided that
the applied ultrafiltration rate is high enough to properly
exploit the high permeability of synthetic membranes.
Besides low ultrafiltration rates, clinical results of the
technique may also be variably affected by the infusion
mode. Indeed, during the postdilution mode, hemoconcen-
tration, and high transmembrane pressure (TMP) can cause
frequent clinical and technical problems, and compromise
the efficiency of the technique. On the other hand, the
predilution mode, while partially preventing these draw-
backs, reduces the cumulative solute transfer as a conse-
quence of the diluted solute concentration available for
diffusion and convection.14–16 Recently, we demonstrated that
mixed HDF (simultaneous pre- and postdilution), compared
to the more traditional infusion modes in HDF, is able to
ensure safer rheological and operating conditions15 and to
produce a significant gain in efficiency when increasing
infusion rates are applied and filtration is forced.7 The
operating conditions necessary to achieve these results were
maintained through the use of a new feedback system,
designed in our department, which is able to control the
filtration pressure and keep the ultrafiltration rate at the
highest safe range during the session by adjusting the pre-/
post-filter infusion ratio according to the patient and dialyzer
characteristics.7 However, some concern arose from the
observation that consistent albumin loss, to such a degree as
to compromise the nutritional status of the patients, may
occur during HDF,17–19 mainly at the beginning of a session
as an effect of the high filtration pressure applied to the intact
membrane.20
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In the light of this, our present attempt was to define the
optimal flow/pressure conditions, which are needed in mixed
HDF to best preserve the permeability properties of synthetic
membranes, in order to fully exploit their transport potential
and obtain maximal efficiency while minimizing potential
side effects, particularly protein loss.
Different profiles of TMP were applied with the aid of the
TMP feedback device and solute removal, fractional albumin
loss, and hydraulic permeability of the membrane were
monitored and compared at various times throughout the
session.
RESULTS
Baseline patient parameters of the two experimental periods
(Table 1) did not differ significantly. The mean TMP
(TMPm) profiles obtained in the two study periods A and
B, in line with the study protocol, are depicted in Figure 1,
with the mean infusion rates at the pre- and postdilution site
of the dialyzer, and their changes during the procedures,
which were managed by the feedback mechanism in order to
maintain the programed TMP profile (see also Table 2). The
total infusion (preþ postdilution) and ultrafiltration rates of
the sessions were similar in both procedures (QS, 178721 ml/
min; QUF, 186720 ml/min). In procedure B, compared with
procedure A, lower TMP values, corresponding to the
planned profile, were maintained at the start of the session
with a higher infusion rate given in predilution. Nevertheless,
at the end of the sessions, the amount of fluid infused in
postdilution was similar for the two procedures, as a result of
the repeated shifts of replacement fluid driven by the device
algorithm. The filtration fraction was lower at the start of
session B (Table 2), as a consequence of the higher rate of
predilution infusion, but as a mean, very high filtration
fraction (FF) were maintained during the sessions of both
study periods, ensuring that the highest possible convective
flux had been achieved.
Efficiency of the procedures and dialyzer performance
No difference was observed between the two TMP profiles in
urea KDQ and eKt/V (Table 3). Instantaneous b2-micro-
globulin (b2-m) dialyzer clearances (Kb2-m), calculated to test
the dialyzer performance in terms of b2-m removal and its
changes over time in dialysis (Figure 2), were significantly
higher in procedure B at the start of the sessions (207735 vs
194728 ml/min, Po0.005), whereas no difference was found
between the two procedures at the end of the session
(135719 vs 13279 ml/min). However, a significant decline
in b2-m K from the start to the end (more than 30% of the
initial value) was recorded with both procedures. The
efficiency in removing middle-sized solutes, calculated from
the amount of b2-m recovered in the total spent dialysate
(MTDQ) and the mean b2-m whole-body clearance (KDQ),
was significantly higher in session B, performed under TMP
modulation (Table 3) than in session A. Together with
methodological reasons implicit in the DQ method,21 solute
absorption on the membrane may explain why b2-m KDQ
values (calculated from the dialysate side) were significantly
lower than the instantaneous Kb2-m values (calculated from
the blood side), and underestimated the actual dialyzer
clearance.
Table 1 | Baseline and end-session patient parameters
Constant TMP Profiled TMP P-value*
N=12 N=12
Urea (mmol/l)
Start 19.673.0 21.674.6 NS
End 3.271.0 3.671.6 NS
b2-m (mg/l)
Start 20.877.6 21.579.8 NS
End 3.971.0 3.571.2 NS
Hematocrit (%)
Start 30.071.7 30.272.1 NS
End 35.573.0 35.872.2 NS
Total protein (g/l)
Start 62.173.8 62.873.0 NS
End 67.773.8 68.773.4 NS
Albumin (g/l)
Start 34.772.7 35.672.0 NS
NS: not significant.
Data are means7s.d. *Student’s t-test for paired data.
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Figure 1 | TMPm profiles (line a) with 95% CI of the 144
experimental procedures a and b, obtained by adjusting the
pre/postdilution infusion ratio under TMP feedback control. At
the start of the session, small shifts of infusion fluid from predilution
(line c) to postdilution (line b) increased the filtration fraction and
stabilized TMP within a close operational range around its maximal
value (300 mmHg). (a) This was achieved rapidly or (b) gradually over
30 min, according to the study protocol. Subsequently, during the
session, TMP values that exceeded the upper limit were reduced by
shifts of infusion fluid in the opposite direction.
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The mean amount of albumin detected in the fractional
dialysate collection in the first 30 min and in the spent
dialysate of the whole sessions was significantly lower in
procedure B (Table 4). In session A, conducted with constant
TMP, the rate of albumin leakage was significantly higher in
the first 30 min than in the rest of the sessions (32.676.0 vs
22.772.7 mg/min, Po0.001), whereas no differences were
found at the different times in session B.
Effects on dialyzer permeability
The behavior of the in vivo ultrafiltration coefficients (KUFD,
ml/h/mmHg of TMP) and of the resistance index (RI¼ PB in/
QB in) of the dialyzers during the sessions (Figures 3 and 4)
indicated a rapid deterioration of the hydraulic membrane
permeability, which occurred mostly during the first half
hour in both procedures, owing to protein layer formation
and its progressive thickening. The phenomenon was similar
for the three employed dialyzers, but it was generally much
more prominent in procedure A, in which KUFD was reduced
in the first few minutes of the sessions. In all cases, only after
about 35 min into the session did the KUFD values of the two
procedures overlap and it remained constant after that.
Slowly increasing TMP according to the planned profile in
procedure B seemed to ensure better preservation of the
hydraulic membrane characteristics and provides a lower risk
pressure regimen inside the dialyzer.
DISCUSSION
When blood starts flowing within the dialyzer and first comes
into contact with the membrane, protein material is attracted
to and adheres to the membrane surface (fouling phenom-
enon). At a low ultrafiltration rate, only small peptides and
proteins are trapped by the membrane pores and adhere to
their inner surface. Compared to the intact membrane, this
narrowing of the pore size leads to larger plasma molecules,
such as albumin, being rejected, whereas permeability to
solutes in the middle molecular range, such as b2-m, is not
substantially modified. When a higher ultrafiltration rate is
applied, protein polarization on the inner membrane surface
Table 2 | Flow rates during the experimental procedures
Constant TMP Profiled TMP P-value*
N=12 N=12
QB eff (ml/min) 391716 390718 NS
QPW (ml/min)
Start 257713 255713 NS
End 235715 233711 NS
QSpre-D (ml/min)
Start 89711 106715 o0.0001
End 117720 115718 NS
QSpost-D (ml/min)
Start 88710 72713 o0.0001
End 61717 63718 NS
QUF (ml/min)
Mean 186721 186720 NS
Filtration fraction (%)
Start 53.673.9 51.373.9 o0.005
End 52.773.4 53.374.2 NS
Mean 53.774.0 53.373.9 NS
Abbreviations and definition of the parameters are in the text (section Materials and
Methods). The filtration fraction was calculated with equation (2). Data are
means7s.d. *Student’s t-test for paired data.
Table 3 | Efficiency of the experimental procedures
Constant TMP Profiled TMP P-value*
N=12 N=12
KDQ Urea (ml/min) 244.0726.0 248.6723.0 NS
eKt/V 1.6770.18 1.7170.25 NS
b2-m MT (mg/session) 187.7768.6 206.2782.3 o0.05
b2-m KDQ (ml/min) 87.8718.3 97.0715.4 o0.01
Abbreviations and definition of the parameters are in the text (section Materials and
Methods). Data are means7s.d. *Student’s t-test for paired data.
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Figure 2 | Instantaneous b2-m clearance at the start and the end
of the experimental procedures A (shaded columns) and B (dark
columns), evaluated from the blood side. Paired Student’s t-test:
(a) profiled vs constant TMP, Po0.005 and (b) start vs end session,
Po0.0001.
Table 4 | Albumin loss during the experimental procedures
Constant TMP Profiled TMP P-valuea
N=12 N=12
Mass in dialysate (g)
Start – 30 min 0.9870.18 0.6270.14 o0.0001
30 min – end 4.2670.78 3.3671.15 o0.05
Total 5.2470.77 3.9871.19 o0.001
Rate of loss (mg/min)
Start – 30 min 32.676.0 20.674.7 o0.0001
30 min – end 22.772.7b 17.875.5 o0.01
Total 24.172.1 18.274.9 o0.001
Data are means7s.d. Student’s t-test for paired data.
aProfiled vs constant TMP sessions.
bStart – 30 min vs 30 min – end periods.
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also takes place, and the thickness of the secondary protein
layer is proportional to the filtration pressure. Under these
conditions, even larger proteins may be pushed into and
entrapped inside the pores, with the effect of a permanent
and significant reduction of membrane permeability.22
Protein leakage is an effect of using high-flux membranes
in convective therapies, which provokes concern, owing to its
negative influence on the nutritional status of the pa-
tients.17,18 High-flux membranes, having generally a cutoff
up to 20 000 Da, may be responsible for massive protein
leakage mainly in the early phase of the session, when high
filtration pressure is applied to the intact membrane and even
large molecules such as albumin may be forced into and cross
the intact pores. Kim et al.20 showed that it was possible to
reduce this negative effect by avoiding aggressive filtration in
the early phase of an HDF session. Two profiled filtration
modes, planned to reduce the initial filtration to a lower level,
resulted in minimal albumin loss and higher b2-m removal
than that in the conventional constant flow or pressure
technique. However, in Kim’s study, a low flow/pressure
profile in the first part of the session and TMP control could
only be obtained by reducing the total exchange volume, with
the effect of also reducing the efficiency of the technique.
Moreover, this experience was only conducted in predilution
HDF, where better rheological conditions occur compared to
postdilution. On the other hand, postdilution, commonly
held as the most efficient infusion mode in HDF, implies
clinical and technical risks in its application. In fact, when
high ultrafiltration rates are applied, blood viscosity and
resistance to flow increase, and progressive protein concen-
tration contributes to a thickening of the secondary
membrane layer, hence limiting its hydraulic and solute
permeability. Excessive hemoconcentration affects trans-
membrane solute transfer and is likely to cause fiber and
dialyzer clotting, and the high pressure required to yield the
planned filtrate flow may cause red cell damage and protein
denaturation, stretching and rupture of the membrane, and
deformation of its pores, through which massive protein
leakage may occur. Even if an increase in UF flux through a
high-flux polysulfone membrane was observed with intra-
venous infusion of hypertonic glucose during postdilution
HDF,23 the events described above are difficult to counteract
by using the ultrafiltration control systems employed on
currently available HDF machines, as these are of little or no
help in planning and carrying out a session in which
ultrafiltration flow or pressure is profiled, or increasingly
higher and unpredictable TMP gradients are automatically
prevented in order to maintain safe operational conditions.
Previous studies have shown that limits and risks implicit
in the traditional infusion modes in HDF may be overcome
with on-line mixed HDF, which ensures more favorable
blood rheology and membrane permeability than in the
postdilution mode, and allows the total infusion to be
increased and convective removal to be forced beyond the
operational limits placed in postdilution. In mixed HDF, this
increased amount of infusion is added in predilution and
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Figure 3 | (a, HF80S; b, FX80; c, FX100) Behavior of the apparent
ultrafiltration coefficient of the dialyzers (KUF D¼QUF/TMP) as a
mean of the on-line records obtained during the experimental
procedures. The characteristics of the dialyzers are described in the
text (section Materials and Methods). Lines a, constant TMP sessions;
lines b, profiled TMP sessions.
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Figure 4 | Behavior of the resistance index (RI¼PB in/QB in), as
recorded on-line for the dialyzer FX100 during the experimental
procedures line a and line b. The trend of RI for the other dialyzers
(HF80S and FX80, not shown) is very similar and overlaps to that
depicted here.
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balanced with that in postdilution in order to ensure the
highest possible filtration fraction, while simultaneously
avoiding dangerous hydrostatic pressures within the dialyzer
and excessive dilution of the inlet solute concentrations. The
very high ultrafiltration rate resulted in a significant increase
in b2-m removal compared to that obtained with the
postdilution mode. This was feasible in a safe way only by
using the feedback device for TMP control developed in our
unit. The device was able to regulate the TMPm at its highest
safe value by means of small shifts (5–10 ml) of substitution
fluid from the postdilution to the predilution infusion site or
vice versa, thus reducing or increasing, respectively, the
filtration fraction, without reducing the planned ultrafiltra-
tion rate.7
In the present study, the careful control of TMP, which
was never permitted to reach dangerous values, allowed
protein loss to be contained within acceptable limits, also
using constantly high TMP values as in procedure A.
However, in agreement with the findings of Kim’s study,
protein leakage was further reduced by applying low filtration
pressure at the beginning of the session and gradually
increasing it to reach the planned value after the first half
hour of the session. This was obtained with the help of the
TMP feedback in mixed HDF without reducing the total
ultrafiltration rate, but only with automatic shifts of small
amounts of the infusion fluid from the postdilution to the
predilution port of the dialyzer. As a final result, the
cumulative albumin loss of the sessions was significantly
lower in those sessions in which TMP was modulated as
above. In addition, profiled TMP applied during mixed HDF
better preserved the hydraulic and solute permeability of the
membrane, as demonstrated by the higher values of the
dialyzer ultrafiltration coefficient and b2-m clearance mea-
sured in the first part of the profiled TMP sessions compared
to those with constant high filtration pressure. This resulted
in significantly increased cumulative b2-m removal.
MATERIALS AND METHODS
This prospective, randomized, cross-over study was approved by the
local Ethics Committee. Twelve uremic patients (three female and
nine male, aged 64.276.6 years), who were on three times weekly
renal replacement therapy, six with HDF for 2.371.2 years and six
with high-flux hemodialysis for 5.273.8 years, gave their informed
consent to the study. The mean body weight was 64.9711.2 kg and
the mean kinetically estimated urea distribution volume (Vu) was
32.177 l. All the patients underwent two study periods of 2 weeks
each with mixed HDF. The sequence of the two study periods was
randomly assigned to the patients. In the first period (period A),
TMP was maintained from the start of the sessions within a strict
range of values around the highest safe value (B300 mmHg),
whereas in the second period (period B), a modulated TMP profile
was applied, in which TMP was gradually increased over about
30 min from low initial values up to the highest. These were then
kept constant throughout the rest of the session, as shown in
Figure 1. A total of 144 sessions were studied. The same high-flux
polysulfone dialyzer in routine use for each patient was used in both
study periods (FX 80 in four patients, FX 100 in four and HDF 100s
in four; all dialyzers are produced by Fresenius, FMC, Bad
Homburg, Germany). The length of the session (t, 218726 min)
and the blood flow rate (QB, 422738 ml/min) were kept constant
for each patient for each session in the study. The effective blood
flow QB eff (i.e. the value for QB corrected for the negative pressure of
the arterial line before the pump and its inner diameter) was
390717 ml/min. The inlet dialysate flow (QD) was 609728 ml/min.
Access flow recirculation, tested in previous routine sessions, was
always less than 10%. Anticoagulation was performed with
unfractionated heparin with the same regimen in all experimental
sessions (initial bolus 50 IU/kg, continuous infusion of
6757187 IU/h).
The TMP feedback control
On-line mixed HDF was performed with a new dialysis machine
(Fresenius 5008, Fresenius, FMC, Bad Homburg, Germany),
equipped with two peristaltic pumps for simultaneous pre- and
postfilter infusion, and a feedback system for TMP control, which
was a further development of a similar device previously validated
on a Fresenius 4008 machine.7 The system operates at the start of
the session by setting the total infusion rate (QS, ml/min) according
to the plasma water flow rate of the patient (QPW, ml/min) and the
ratio between pre- and postinfusion rates (QSpre/QSpost) according to
the desired FF.
QPW is calculated from QB eff, hematocrit (Hct) and the water
fraction of plasma (Fp) with the classic equation:
24
QPW ¼ QB eff ð1  Hct=100ÞFp ð1Þ
FF is defined arbitrarily as the fraction of QPW ultrafiltered during
the passage through the dialyzer, in analogy with a more strict
definition:25
FF ¼ ð1  QPW out=QPW inÞ ¼ QUF=QPW in ð2Þ
where QUF equals the total ultrafiltration rate (QS plus the rate of
body weight decrease, in ml/min), QPW in is the plasma water flow
rate entering the dialyzer that, as here in the case of mixed pre- and
postinfusion, equals the plasma water flow rate of the patient (QPW)
added to the preinfusion rate (QSpre):
QPW in ¼ QPW þ QSpre ð3Þ
and QPWout is the outlet plasma water flow rate:
QPW out ¼ QPW in  QUF ð4Þ
Different options are available both for QS as a function of QPW in
(QS/QPW in from 0.6 to 1.0), and for FF from 0.3 to 0.5 in steps of
0.05. In this study, a mean individual ratio QS/QPW in of 0.7 (range
0.6–0.8) and an initial FF of B0.5 were set on the basis of previous
experience7 and the results of pilot sessions in which different
infusion flow distributions (and FF) were tested to obtain the
desired TMP profile in each patient. The split between pre- and
postinfusion rate (ml/min) was computed by the software device
according to the set FF and the following equations, derived from
equations (2) and (3):
QSpre ¼ ðQUF  FF  QPWÞ=FF ð5Þ
and,
QSpost ¼ QS  QSpre ð6Þ
After the initial setting, as described elsewhere,7,26 the machine starts
to record real-time values for the pressures at the inlet and outlet
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blood and dialysate ports (PB in, PB out, PD in, PD out, respectively,
mmHg) by means of four pressure transducers connected to an
external computer, and the mean TMP within the dialyzer (TMPm,
mmHg) is calculated instantaneously using the following equation:
TMPm ¼0:5ððPB in þ PB outÞ
 ðPD in þ PD outÞÞ  p0
ð7Þ
where p0 (mmHg) is the mean oncotic pressure exerted by the
plasma proteins, set by default to a constant value of 25 mmHg.
Subsequently, the feedback acts to maintain TMPm values within
the programed range, which can be constant, as in the experimental
period A, or variably profiled, as in period B. This task is
accomplished by adjusting the ratio of pre- to postinfusion, and thus
FF, without changing the total QUF: a small amount of fluid (5–10 ml/
min) is diverted from pre- to postinfusion if TMPm drops below the
established lowest limit or, vice versa, from post- to predilution,
whenever TMPm rises beyond its maximum tolerated value
(300 mmHg). The net effect is, respectively, to increase or decrease
FF and thus to maintain the highest filtration pressure compatible
with the increase in hemoconcentration and loss of hydraulic
membrane permeability, which occurs as the session progresses.
The machine software recorded and computed signals able to
monitor the pressure drop within the dialyzer, the resistance index
(RI¼ PB in/QB in) and the values for the in vivo ultrafiltration
coefficients (KUFD, ml/h/mmHg of TMP) of the dialyzers, which
were used as a proxy to evaluate changes in the hydraulic
permeability of the dialyzer during the sessions.
Solute removal
The mid-week session of the second week of each experimental
period was chosen to test the efficiency of the treatments.
The mean efficiency of each session was evaluated using the part-
ial dialysate quantification (DQ) method.27 The effluent dialysate,
collected at a constant rate over the session with a proportional
pump, was processed for urea, b2-m, and albumin concentration
(Cd). Separate dialysate collection of the first half hour was per-
formed for albumin loss quantification. Blood samples were drawn
from the arterial port at the start and at the end (slow-flux
technique) of the sessions and plasma concentrations (Ci, Cf) were
measured for urea (60 kDa) and b2-m (11.8 kDa), taken as markers
of the low and medium-high molecular weight toxins, respectively.
The mass of solute removed during each session (MTDQ) was cal-
culated from the effluent dialysate sample (B50 ml), representative
of the whole spent dialysate (Vd), as in:
MTDQ ¼ CdVd ð8Þ
The following equation of the DQ method was used to calculate the
mean dialysate clearances of the session KDQ:
27
KDQ ¼ ½MTDQ lnðCf=CiÞ	=½tðCf CiÞ	 ð9Þ
Calculated as above, MTDQ and KDQ underestimate the actual b2-m
removal, because of the amount of solute absorbed on the
membrane and not detectable in dialysate collection. However, this
systematic and constant error is unlikely to affect the results of a
comparison between the different procedures in the same patient
and with the same dialyzer.
The equilibrated Kt/V (eKt/V) for urea was estimated from urea
KDQ and Vu, and the session time (t).
Dialyzer performance in MM removal at different times of the
session was evaluated by calculating b2-m instantaneous dialyzer
clearances (Kb2-m) 5 min after the start and before the end of the
session. For this purpose, blood samples were drawn simultaneously
from the inlet and outlet blood port of the dialyzer, and plasma
water b2-m concentration (Cart, Cven), hematocrit and total plasma
protein (TP) concentration were measured. The classic equation for
the solute mass transport was applied to calculate K:24
Kb2m ¼ QPWðCart  CvenÞ=Cart þ QUFCven=Cart ð10Þ
Immunonephelometry was used to measure b2-m and albumin in
both plasma and dialysate.
Statistical analysis
The descriptive analysis was based on the mean7s.d. values of
continuous normally distributed variables. The effects of the two
procedures on parameters of treatment efficiency (KDQ, urea Kt/V,
and MTDQ) were compared with the Student’s t-test for paired data.
A probability value of less than 0.05 was considered significant.
CONCLUSIONS
Mixed HDF has already been shown to be a highly effective
technique to remove uremic solutes of middle molecular
weight, while avoiding the known drawbacks of the
traditional infusion modes. The application of the TMP
feedback control system, which modulates the filtration
pressure in order to preserve the hydraulic and solute
permeability of the membrane, further increased the
efficiency of the technique and minimized albumin leakage.
The high biocompatibility resulting from the use of synthetic
membranes and ultrapure dialysate/substitute prepared on-
line with double ultrafiltration, combined with the enhanced
removal of small and middle molecular uremic toxins, seems
to indicate that TMP-modulated mixed HDF is an effective
strategy to prevent or delay the occurrence of long-term
dialysis complications and to promote improved survival of
dialysis patients.
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